← Back to work
Works citing this work
1 works
Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”
Shobana Chandrasekar, M.K. Rohith Krishnan, Umesh Kumar
ArticleMultiple Myeloma Research and TreatmentsJournal of the Formosan Medical Association20260 citationsABI